Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02060903 · ClinicalTrials.gov registry record · Phase 3
A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
A Phase 3 study, sponsored by Dr. Reddy's Laboratories Limited.
- Completed
- Registry status
- Phase 3
- Development phase
- 379
- Enrollment target
NCT02060903 is a Phase 3 study that has completed, run by Dr. Reddy's Laboratories Limited. The registered enrollment target is 379 participants.
The verdict
NCT02060903, a Phase 3 study, has completed, sponsored by Dr. Reddy's Laboratories Limited.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 379 participants
- Enrollment target
Study Summary
The purpose of the study was to assess the efficacy, safety and tolerability of a single application of abametapir lotion 0.74% w/w compared to a vehicle control, when applied to the scalp and hair for 10 minutes at home.
Interventions
- DRUG Vehicle Lotion
- DRUG Abametapir Lotion 0.74% w/w
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 379 participants |
| Start Date | 2014-02 |
| Est. Completion | 2014-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02060903
The ClinicalTrials.gov registry entry for NCT02060903 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 379 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dr. Reddy's Laboratories Limited, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle Lotion is the first listed.
NCT02060903 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02060903 about?
NCT02060903 is a clinical study titled "A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation". The purpose of the study was to assess the efficacy, safety and tolerability of a single application of abametapir lotion 0.74% w/w compared to a vehicle control, when applied to the scalp and hair for 10 minutes at home.
What is the current status of trial NCT02060903?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 379 participants. The study started on 2014-02. Estimated completion is 2014-08.
What interventions are being tested in trial NCT02060903?
The interventions under investigation include: Vehicle Lotion (DRUG), Abametapir Lotion 0.74% w/w (DRUG).
Who is sponsoring clinical trial NCT02060903?
This trial is sponsored by Dr. Reddy's Laboratories Limited, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.